Used in biomedical research to quantify erythropoietin receptor (EPOR) levels in cell lysates, tissue extracts, and biological fluids. Enables researchers to study EPOR expression in various physiological and pathological conditions, such as anemia, cancer, and neurodegenerative diseases. Supports investigation into erythropoietin signaling pathways and helps evaluate the efficacy of erythropoiesis-stimulating agents in preclinical studies. Widely applied in pharmaceutical development and molecular biology labs for high-throughput screening and biomarker validation.